Order Article Reprints

Cameli P, Alonzi V, d’Alessandro M, Bergantini L, Pordon E, Guerrieri M, Refini RM, Sestini P, Bargagli E. The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study. Biomedicines. 2022; 10(8):1973. https://doi.org/10.3390/biomedicines10081973

Cameli, Paolo, Valerio Alonzi, Miriana d’Alessandro, Laura Bergantini, Elena Pordon, Marco Guerrieri, Rosa Metella Refini, Piersante Sestini, and Elena Bargagli. 2022. "The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study" Biomedicines 10, no. 8: 1973. https://doi.org/10.3390/biomedicines10081973

Cameli, P., Alonzi, V., d’Alessandro, M., Bergantini, L., Pordon, E., Guerrieri, M., Refini, R. M., Sestini, P., & Bargagli, E. (2022). The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study. Biomedicines, 10(8), 1973. https://doi.org/10.3390/biomedicines10081973